Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Leases (2016 - 2025)

Historic Leases for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 14 years, with Q1 2025 value amounting to $2.2 million.

  • Lifecore Biomedical, Inc. \De\'s Leases fell 1103.59% to $2.2 million in Q1 2025 from the same period last year, while for Feb 2025 it was $2.2 million, marking a year-over-year decrease of 1103.59%. This contributed to the annual value of $2.4 million for FY2024, which is 4297.06% down from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Leases of $2.2 million as of Q1 2025, which was down 1103.59% from $2.3 million recorded in Q4 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Leases registered a high of $15.4 million during Q1 2021, and its lowest value of $2.2 million during Q1 2025.
  • Moreover, its 5-year median value for Leases was $5.1 million (2023), whereas its average is $5.6 million.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Leases plummeted by 6297.47% in 2022 and then plummeted by 1057.34% in 2023.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Leases stood at $7.5 million in 2021, then dropped by 29.87% to $5.3 million in 2022, then decreased by 23.14% to $4.0 million in 2023, then tumbled by 42.91% to $2.3 million in 2024, then fell by 3.08% to $2.2 million in 2025.
  • Its Leases stands at $2.2 million for Q1 2025, versus $2.3 million for Q4 2024 and $2.4 million for Q3 2024.